Long Term Follow up of the LTOG Cohort
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT04787822
- Status
- Enrolling By Invitation
Conditions
- Lung Transplant Failure and Rejection
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.
Key Dates
- Start date
- Jun 15, 2021
- Status verified
- Jun 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 4,000 participants (estimated)
Primary Outcome Measure
Chronic Lung Allograft Dysfunction (CLAD) phenotyping [ Time Frame: From date of transplant to the development of CLAD, up to 25 years ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35294 | - |
| University of California San Francisco | San Francisco | California | 94143 | - |
| Stanford University | Stanford | California | 94305 | - |
| Indiana University | Indianapolis | Indiana | 46202 | - |
| Johns Hopkins University | Baltimore | Maryland | 21224 | - |
| University of Michigan | Ann Arbor | Michigan | 48109 | - |
| Columbia University | New York | New York | 10027 | - |
| Duke University | Durham | North Carolina | 27710 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | - |
Find similar trials in Birmingham, AL
Related Studies
- Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLADNot Yet Recruiting · Brian Keller · Boston, Massachusetts